Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 9Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Barrett Esophagus 3Stomach Neoplasms 2Recurrence 2Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Multiple Pulmonary Nodules 2Melanoma 2Glioma 2Colorectal Neoplasms 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Spinal Fractures 1Solitary Pulmonary Nodule 1Smoking Cessation 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Phyllodes Tumor 1Osteoporosis 1Nevus 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Lymphoma, Follicular 1Lung Diseases 1

Interventions

Temozolomide 159Bevacizumab 69Radiotherapy 68Magnetic Resonance Spectroscopy 68Irinotecan 31Surgical Procedures, Operative 27Radiation 24Carboplatin 23Specimen Handling 20Carmustine 20Blood Specimen Collection 20Nivolumab 19Aminolevulinic Acid 18Biopsy 17Lomustine 16pembrolizumab 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13trametinib 12fluorodopa F 18 12X-Rays 12Radiosurgery 12Erlotinib Hydrochloride 12Topotecan 11Everolimus 11Magnetic Resonance Imaging 10IL13-PE38 10dabrafenib 9Etoposide 9Drug Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glioma × Diagnostic Imaging × Clear all
NCT05274919 2025-03-10

VASIM

Leiden University Medical Center

Recruiting
180 enrolled
CNS

Glioma

NCT00137488 2016-02-26

Angiogenic Profile and Non-invasive Imaging May Predict Tumor Progression of High Risk Group Low Grade Glioma (LGG)

AHS Cancer Control Alberta

Completed
10 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡